Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $65,000 | 1 | 88.3% |
| Food and Beverage | $5,053 | 221 | 6.9% |
| Debt forgiveness | $2,800 | 1 | 3.8% |
| Education | $757.70 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $65,977 | 60 | $0 (2024) |
| ConvaTec Inc. | $2,800 | 1 | $0 (2024) |
| Melinta Therapeutics, LLC | $1,116 | 51 | $0 (2023) |
| Pylant Medical | $757.00 | 1 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $573.50 | 24 | $0 (2024) |
| Organogenesis Inc. | $430.68 | 13 | $0 (2024) |
| Horizon Therapeutics plc | $255.56 | 6 | $0 (2022) |
| BIOTISSUE HOLDINGS, INC. | $252.55 | 3 | $0 (2023) |
| Sebela Pharmaceuticals Inc. | $179.98 | 9 | $0 (2019) |
| IMBED BIOSCIENCES INC. | $158.95 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,190 | 22 | ConvaTec Inc. ($2,800) |
| 2023 | $1,221 | 44 | Paratek Pharmaceuticals, Inc. ($331.01) |
| 2022 | $831.57 | 28 | Melinta Therapeutics, LLC ($250.83) |
| 2021 | $289.02 | 21 | Melinta Therapeutics, LLC ($155.49) |
| 2020 | $65,210 | 15 | Smith+Nephew, Inc. ($65,048) |
| 2019 | $1,009 | 55 | Melinta Therapeutics, Inc. ($159.68) |
| 2018 | $1,658 | 31 | Pylant Medical ($757.00) |
| 2017 | $201.13 | 9 | Organogenesis Inc. ($81.91) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), REGRANEX | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Pharma Products | ||||||
| 11/27/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: ANTIBIOTIC | ||||||
| 11/01/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: WOUND CARE | ||||||
| 10/31/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: ANTIBIOTIC | ||||||
| 09/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: ANTIBIOTIC | ||||||
| 09/03/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Pharma Products | ||||||
| 08/04/2024 | MEDELA LLC | Invia Motion Endure (Device) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: NPWT | ||||||
| 07/24/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 07/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: ANTIBIOTIC | ||||||
| 06/27/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Debt forgiveness | Cash or cash equivalent | $2,800.00 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 06/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: ANTIBIOTIC | ||||||
| 05/14/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 05/08/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $25.64 | General |
| 04/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: ANTIBIOTIC | ||||||
| 03/20/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ANTIBIOTIC | ||||||
| 03/06/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Pharma Products | ||||||
| 03/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: ANTIBIOTIC | ||||||
| 02/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $118.06 | General |
| Category: ANTIBIOTIC | ||||||
| 02/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: ANTIBIOTIC | ||||||
| 02/01/2024 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Pharma Products | ||||||
| 01/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: ANTIBIOTIC | ||||||
| 01/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: ANTIBIOTIC | ||||||
| 12/05/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Pharma Products | ||||||
| 11/29/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: ANTIBIOTIC | ||||||
| 11/21/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Pharma Products | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 376 | 4,550 | $394,317 | $191,724 |
| 2022 | 9 | 226 | 3,499 | $285,956 | $143,566 |
| 2021 | 7 | 233 | 989 | $128,931 | $64,566 |
| 2020 | 15 | 411 | 2,227 | $228,398 | $105,327 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 48 | 2,574 | $180,180 | $88,516 | 49.1% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 29 | 498 | $69,720 | $34,261 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 506 | $66,286 | $32,953 | 49.7% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 48 | 198 | $13,860 | $6,809 | 49.1% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 19 | 86 | $12,470 | $6,311 | 50.6% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 29 | 166 | $11,620 | $5,709 | 49.1% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 29 | 166 | $11,620 | $5,709 | 49.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 29 | 166 | $11,620 | $5,709 | 49.1% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 33 | 97 | $8,051 | $3,073 | 38.2% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 27 | 32 | $2,240 | $1,100 | 49.1% |
| 0640T | Noncontact near-infrared spectroscopy study of flap or wound with image acquisition, interpretation and report, each flap or wound | Office | 2023 | 17 | 50 | $5,000 | $930.49 | 18.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 11 | 11 | $1,650 | $643.75 | 39.0% |
| J2406 | Injection, oritavancin (kimyrsa), 10 mg | Office | 2022 | 11 | 1,920 | $124,800 | $63,824 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 599 | $78,469 | $40,004 | 51.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 18 | 637 | $44,590 | $21,905 | 49.1% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 24 | 134 | $19,430 | $10,303 | 53.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 47 | 117 | $9,711 | $3,753 | 38.6% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 18 | 49 | $3,430 | $1,685 | 49.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 12 | 20 | $2,800 | $1,040 | 37.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,956 | $673.29 | 34.4% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 11 | 11 | $770.00 | $378.29 | 49.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 625 | $81,875 | $43,123 | 52.7% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Office | 2021 | 34 | 151 | $21,895 | $11,598 | 53.0% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 44 | 111 | $9,213 | $3,719 | 40.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 51 | $4,590 | $2,060 | 44.9% |
About Dr. Anna Sanchez, DPM
Dr. Anna Sanchez, DPM is a Podiatrist healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881780468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Sanchez, DPM has received a total of $73,611 in payments from pharmaceutical and medical device companies, with $3,190 received in 2024. These payments were reported across 225 transactions from 32 companies. The most common payment nature is "Gift" ($65,000).
As a Medicare-enrolled provider, Sanchez has provided services to 1,246 Medicare beneficiaries, totaling 11,265 services with total Medicare billing of $505,183. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Location San Antonio, TX
- Active Since 10/04/2006
- Last Updated 11/01/2022
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1881780468
Products in Payments
- GRAFIX PL (Biological) $65,000
- INNOVAMATRIX AC (Device) $2,890
- NUZYRA (Drug) $573.50
- Baxdela (Drug) $436.14
- Orbactiv (Drug) $345.64
- Kimyrsa (Drug) $334.27
- COLLAGENASE SANTYL (Drug) $291.50
- REGRANEX (Drug) $272.65
- KRYSTEXXA (Biological) $255.56
- NAFTIN (Drug) $165.35
- Puraply (Medical Supply) $150.84
- DALVANCE (Drug) $142.79
- Regranex (Drug) $140.92
- BBA - Amnion (Device) $112.00
- Puracol Collagen Dressi (Device) $91.57
- Santyl (Drug) $87.72
- SkinTE (Biological) $86.15
- Affinity (Biological) $81.91
- Apligraf (Biological) $77.17
- Proclaim Family of SCS IPGs (Device) $66.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Podiatrist Doctors in San Antonio
Dr. Ian Barron, Dpm, DPM
Podiatrist — Payments: $135,752
Thomas Zgonis, D.p.m, D.P.M
Podiatrist — Payments: $117,441
Dr. Lawrence Lavery, D.p.m, D.P.M
Podiatrist — Payments: $72,875
Collin Pehde, D.p.m, D.P.M
Podiatrist — Payments: $56,042
Dr. Morris Stribling, D.p.m, D.P.M
Podiatrist — Payments: $33,242
Stephanie Wu, Dpm, DPM
Podiatrist — Payments: $16,796